ARCHIVES

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

This article is from The Cancer Letter archive.

Vol. 30 No. 16 | April 16, 2004

Download PDF Visit The Full Archive

Related Articles

Small Business Technology Transfer Program Solicitation

June 23, 1995

Clinton R&D Budget Amounts to a Cut, AAAS Study Says

April 18, 1997

In Brief: Innovative Antismoking Efforts Needed, CCRAC Told, Illinois To Go After Neutron Contract

December 8, 1978

Cancer Program Should Get $2 Billion A Year, Amos Says; “Feds Short On Money, Long of Regs”: Yarbro

March 25, 1983

NCI Takes Action Against Investigators Who Gave Drug Without An IND; M.D. Anderson Contract Canceled

August 28, 1981

Why Did DeVita Resign MSK Post? Clash Of Style, Other Serious Issues Pointed To By Colleagues

June 7, 1991